Jarin Chindaprasirt

13PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyNutrigenomics and personalised nutritionEpidemiological methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 29, 2026
Prospective Phase II Study of Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma (NEOFOL).

|Sep 24, 2026
Metabolic and Inflammatory Risk Stratification in Resected Cholangiocarcinoma: A Retrospective Exploratory Analysis.

|Sep 09, 2026
Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA Study.

|Jan 21, 2026
Preoperative Prognostic Score for Patients with Intrahepatic Cholangiocarcinoma Undergoing Curative-Intent Resection.

Jarin Chindaprasirt, Thanachai Sanlung, Piyakarn Watcharenwong

|Oct 29, 2025
Prevalence and Related Factors of Post-ERCP Pancreatitis in Cholangiocarcinoma Patients: A Retrospective Study in Northeast Thailand.

Tanapoom Karntaumporn, Vasin Thanasukarn, Tharatip Srisuk

|Sep 13, 2025
Distinct Gut Microbiota Profiles Associated with Advanced Hepatocellular Carcinoma in a Thai Cohort: A 16S rRNA Sequencing Study.

Thanakorn Charoenthanadhol, Jutarop Phetcharaburanin, Theerayut Bubpamala

Pageof 3

Frequent Collaborators

4 joint publications

Watcharin Loilome

2 joint publications

Poramate Klanrit

2 joint publications

Tharatip Srisuk

2 joint publications

Chaiwat Aphivatanasiri